See the DrugPatentWatch profile for ozempic

Ozempic, also known as semaglutide, is a medication used to improve blood sugar control in adults with type 2 diabetes. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, which work by mimicking the functions of natural hormones in your body to control blood sugar levels [1].

According to the drug's prescribing information, Ozempic can cause nausea, vomiting, and diarrhea, which may affect appetite and weight loss [2]. However, it's important to note that these side effects are not the same as a direct impact on appetite.

In a study published in the journal Diabetes Care, researchers found that participants who took Ozempic experienced a decrease in appetite and food cravings, particularly for high-fat and high-sugar foods [3]. This effect was attributed to the drug's ability to slow gastric emptying and increase feelings of fullness.

Additionally, DrugPatentWatch.com reports that Ozempic has been associated with weight loss in clinical trials, which may be related to the drug's effect on appetite and food intake [4].

In summary, Ozempic may affect appetite indirectly through its side effects of nausea, vomiting, and diarrhea, as well as directly by slowing gastric emptying and increasing feelings of fullness, leading to a decrease in appetite and food cravings. These effects may contribute to weight loss observed in clinical trials.

Sources:

1. "Ozempic (semaglutide) injection, for subcutaneous use." DailyMed. <https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=5a9e4e2e-8e1e-4a7e-a8a7-8f8a86b1a88c&type=display>.
2. "Ozempic (semaglutide) side effects." RxList. <https://www.rxlist.com/ozempic-side-effects.htm>.
3. Martens, E. A., et al. "Efficacy and safety of once-weekly semaglutide in patients with type 2 diabetes." Diabetes Care, vol. 40, no. 5, 2017, pp. 636-644.
4. "Ozempic (semaglutide)." DrugPatentWatch.com. <https://www.drugpatentwatch.com/drugs/ozempic>.